Concordia Healthcare Corp. T.CXR.R

WSJ Article

[Marcel7]

New article lumping Concordia in with Valeant, Horizon Pharma and Mallinckrodt.

https://www.wsj.com/articles/concerns-over-valeant-spread-to-other-drug-makers-1448240861

Looks like either poor research into Concordia or outright distortion. Here are some highlights:

"Concordia didn’t respond to requests for comment, but has said its drug prices are competitive with other products on the market."

"Concordia Healthcare is among the most aggressive newcomers to build its business through acquiring older or off-patent drugs and raising their prices significantly, says Jessica Gladstone, an analyst at Moody’s Investors Service."

I find this 2nd quote very curious, as Concordia has been relatively aggressive in the acquisitions, but certainly can not be considered to be even close to the most aggressive in price increases. I am looking through all of the available articles of Jessica Gladstone on Moody's but cannot find a similar quote. I have emailed the author directly asking for clarification on the source of this.

GL all.

[argentia77]

Nice find marcel. Another thing that bothers me about the artice is how the graphic at the top inappropriately compares R&D spending of Concordia (MC=$2.69B) with that of Bristol Myers (MC=$112.89B and Pfizer (MC=$194B). Reminds me of when a disingenuous finance minister says the average annual income of his constutuents is $57,000 when for every nine that get $30,000, one gets $300,000.

[slightfan1]

as my accounting teacher told my class many years ago... figures don't lie but liars figure. lol so true.